Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Twist Bioscience Corp
(NQ:
TWST
)
44.95
+0.08 (+0.18%)
Streaming Delayed Price
Updated: 10:10 AM EDT, May 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Twist Bioscience Corp
< Previous
1
2
3
4
5
6
7
8
9
Next >
Twist Bioscience Launches Multiplexed Gene Fragments to Enable High-throughput Screening Applications
May 13, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
May 08, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Reports Fiscal Second Quarter 2024 Financial Results
May 02, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Corp. (NASDAQ: TWST) Near the Top of Equities by Percentage Gain on 11/17
November 17, 2023
Via
Investor Brand Network
Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024
April 18, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations
March 28, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome Sequencing
March 05, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Present at Upcoming Investor Conferences
February 22, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
February 07, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience and Element Biosciences Collaborate on Exome Sequencing Solutions for AVITI System
February 06, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Launches cfDNA Library Preparation Kit for Liquid Biopsy Applications
February 06, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Unveils Differentiated Ultra High-Throughput Library Preparation Solution at AGBT
February 05, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Reports Fiscal First Quarter 2024 Financial Results
February 02, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Expands Express Genes Rapid Synthesis Service
January 24, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Report Fiscal 2024 First Quarter Financial Results on Friday, February 2, 2024
January 16, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Corporation Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
January 08, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Appoints Adam Laponis as Chief Financial Officer
January 05, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Present at 42nd Annual J.P. Morgan Healthcare Conference
December 18, 2023
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Reports Fiscal Fourth Quarter and Full Year Fiscal 2023 Financial Results
November 17, 2023
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Launches Express Genes Rapid Gene Synthesis Service
November 14, 2023
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Present at 6th Annual Evercore ISI HealthCONx Conference
November 13, 2023
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
November 08, 2023
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Report Fiscal 2023 Fourth Quarter and Full Year Financial Results on Friday, November 17, 2023
November 02, 2023
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Launches Full Length Unique Dual Index Adapters to Enable PCR-free Whole Genome Sequencing
October 31, 2023
From
Twist Bioscience Corporation
Via
Business Wire
TWIST ALERT: Bragar Eagel & Squire, P.C. is Investigating Twist Bioscience Corp on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
October 05, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Twist Bioscience Enters into Antibody Discovery and Licensing Option Agreement with Bayer of up to $188 Million
October 05, 2023
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Appoints Mark Buck as Senior Vice President, Operations
October 03, 2023
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience and IMIDomics Collaborate to Discover Antibodies for Applications in Immune-Mediated Inflammatory Diseases
September 27, 2023
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Present at Upcoming Investor Conferences
September 05, 2023
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Enters into Agreement with Ono Pharmaceutical to Discover Novel Antibodies for Autoimmune Diseases
August 31, 2023
From
Twist Bioscience Corporation
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.